Buy or sell BlueWillow Biologics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

BlueWillow Biologics Stock

BlueWillow Biologics operates as a clinical-stage privately-held biopharmaceutical company.

About BlueWillow Biologics Stock

BlueWillow Biologics operates as a clinical-stage privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.

Funding History

October 2006$30.0M
February 2009$12.0M
July 2009$10.0M
November 2010$6.0M
November 2012$11.0M
October 2013$5.5M
February 2016$1.8M
May 2018$10.0M

Management

Sr. Vice President, Vaccine Research & Development

Ali I. Fattom

Member Of The Board Of Directors

Robert C. Moellering

Sr. Vice President, Development

Lyou-Fu Ma

Founder

James R Baker

Member Of The Board Of Directors

Peter G. Ulrich

Member Of The Board Of Directors

David M. Stout

Vice President, Clinical Research

Mary R. Flack

Member Of The Board Of Directors

Anjali V. Jolly

Vice President, Regulatory Affairs

Stephen Gracon

Member Of The Board Of Directors

Ronald M. Cresswell

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from BlueWillow Biologics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo